RJ

Ritam Jain

Active Director Designated Partner DIN 11027799
DIN 11027799 First appointment Mar 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Ritam Jain

Data last updated:

Ritam Jain is a Designated Partner at Jacnova Pharmaceuticals Llp (since 2025). The company operates in Pharma.

DIN 11027799
Primary Designation Designated Partner
Industry Pharma
First Appointment 29 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner29 Mar 20252025Active

Board colleagues of Ritam Jain

NameDINCompanyDesignation
Ajay Kumar Jain11027798Jacnova Pharmaceuticals LlpDesignated Partner
Manav Jain11027800Jacnova Pharmaceuticals LlpDesignated Partner
Naman Jain11027801Jacnova Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Jacnova Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Ritam Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ritam Jain

Ritam Jain currently holds 1 directorship: Jacnova Pharmaceuticals Llp (Designated Partner, since 29 Mar 2025).

Ritam Jain was first appointed on 29 Mar 2025 as Designated Partner at Jacnova Pharmaceuticals Llp.

The current boards of Ritam Jain's companies include Ajay Kumar Jain (Jacnova Pharmaceuticals Llp), Manav Jain (Jacnova Pharmaceuticals Llp), Naman Jain (Jacnova Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available